{"id":"https://openalex.org/W2402969650","doi":null,"title":"A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters.","display_name":"A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters.","alternate_titles":[],"publication_year":1990,"publication_date":"1990-06-01","ids":{"openalex":"https://openalex.org/W2402969650","mag":"2402969650","pmid":"https://pubmed.ncbi.nlm.nih.gov/2146452"},"language":"en","primary_location":{"id":"pmid:2146452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2146452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2402969650"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110564063","display_name":"R. Garraffo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201841394","display_name":"Universit\u00e9 C\u00f4te d'Azur","ror":"https://ror.org/019tgvf94","country_code":"FR","type":"education","lineage":["https://openalex.org/I201841394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Garraffo","raw_affiliation_strings":["Department of Pharmacology, Facult\u00e9 de M\u00e9dicine, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Facult\u00e9 de M\u00e9dicine, Nice, France","institution_ids":["https://openalex.org/I201841394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077270648","display_name":"P. Dellamonica","orcid":"https://orcid.org/0000-0002-2194-3388","observed_orcids":["https://orcid.org/0000-0002-2194-3388"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Dellamonica","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004381545","display_name":"Drugeon Hb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H B Drugeon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044821724","display_name":"H Etesse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Etesse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112825000","display_name":"P Lapalus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Lapalus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7593,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.66413994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"12","issue":"5","first_page":"325","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9359999895095825},{"id":"https://openalex.org/keywords/killing-curves","display_name":"killing curves","score":0.878000020980835},{"id":"https://openalex.org/keywords/antibiotic-efficacy","display_name":"antibiotic efficacy","score":0.47200000286102295},{"id":"https://openalex.org/keywords/teicoplanin","display_name":"teicoplanin","score":0.7609999775886536},{"id":"https://openalex.org/keywords/amikacin","display_name":"amikacin","score":1.0},{"id":"https://openalex.org/keywords/ofloxacin","display_name":"ofloxacin","score":1.0},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8517833948135376},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.7279446125030518},{"id":"https://openalex.org/C2778049240","wikidata":"https://www.wikidata.org/wiki/Q411447","display_name":"Ofloxacin","level":4,"score":0.5694316029548645},{"id":"https://openalex.org/C2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","level":3,"score":0.5501488447189331},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5443491339683533},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5088289380073547},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.49984145164489746},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.457142174243927},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2720984220504761},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2021409273147583},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.16119742393493652},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.10528713464736938}],"mesh":[{"descriptor_ui":"D000583","descriptor_name":"Amikacin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000583","descriptor_name":"Amikacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006020","descriptor_name":"Glycopeptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006020","descriptor_name":"Glycopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013212","descriptor_name":"Staphylococcus epidermidis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015242","descriptor_name":"Ofloxacin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015242","descriptor_name":"Ofloxacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017334","descriptor_name":"Teicoplanin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2146452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2146452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Clinical Trial"},{"id":"mag:2402969650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2146452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2408878284","https://openalex.org/W192539594","https://openalex.org/W2113717321","https://openalex.org/W2230555963","https://openalex.org/W2166840599","https://openalex.org/W2035971419","https://openalex.org/W1975713716","https://openalex.org/W2404836473","https://openalex.org/W2281243305","https://openalex.org/W2769347502"],"abstract_inverted_index":{"Antibiotic":[0],"therapy":[1,58],"is":[2,20,45,64,74,108],"directed":[3],"against":[4],"bacteria":[5],"responsible":[6],"for":[7,200],"infectious":[8],"pathology":[9],"which":[10],"are":[11,54],"able":[12],"to":[13,125,135,183],"resist":[14],"treatment":[15],"mainly":[16],"when":[17],"the":[18,25,41,62,71,88,94,97,101,112,118,149,163,172],"dosage":[19,27,174],"misadapted.":[21],"The":[22,38,68,141],"choice":[23],"of":[24,40,70,96,106,138,144,153,160,165,171,202],"initial":[26],"regimen":[28],"actually":[29],"takes":[30,84],"into":[31,85],"account":[32,86],"toxicological,":[33],"bacteriological":[34,43,133],"and":[35,60,132,148,188,190],"pharmacokinetic":[36,72,131,146],"parameters.":[37],"determination":[39],"classical":[42],"data":[44,134],"performed":[46],"in":[47,76],"vitro":[48],"using":[49],"fixed":[50],"drug":[51,89,139],"concentrations":[52],"that":[53],"far":[55],"from":[56,111],"human":[57],"conditions,":[59],"moreover":[61],"efficiency":[63],"not":[65],"well":[66],"defined.":[67],"estimation":[69,147],"parameters":[73],"realized":[75],"animals,":[77],"healthy":[78],"subjects":[79],"or":[80,194],"ill":[81],"patients":[82],"but":[83],"only":[87],"disposition":[90],"without":[91,114],"correspondence":[92],"with":[93,197],"kinetics":[95],"antibiotic":[98,155],"effect":[99],"on":[100],"bacteria.":[102],"Thus,":[103],"each":[104],"type":[105,159],"evaluation":[107,143],"made":[109],"independently":[110],"others":[113],"any":[115],"correlation":[116],"between":[117],"observed":[119],"phenomena.":[120],"It":[121],"appears,":[122],"therefore,":[123],"interesting":[124,198],"propose":[126],"a":[127,168,192],"new":[128],"approach":[129],"including":[130],"enable":[136],"approximation":[137],"efficacy.":[140],"coupled":[142],"individual":[145],"killing":[150],"curve":[151],"determinations":[152],"an":[154],"will":[156],"allow":[157],"this":[158],"development.":[161],"On":[162],"basis":[164],"these":[166],"data,":[167],"preliminary":[169],"profile":[170],"optimal":[173],"would":[175],"be":[176],"possible.":[177],"This":[178],"methodology":[179],"has":[180],"been":[181],"applied":[182],"three":[184],"antibiotics:":[185],"teicoplanin,":[186],"amikacin":[187],"ofloxacin":[189],"demonstrates":[191],"time-":[193],"dose-dependent":[195],"activity,":[196],"possibilities":[199],"optimization":[201],"dosage.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2402969650","counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
